ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism - ScienceDirect
ACLY inhibition impairs glucose and lipid metabolism in A549 cells. A,... | Download Scientific Diagram
Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma
The ATP-citrate Lyase (ACLY) Project
Adenosine Triphosphate Citrate Synthase Inhibitor - an overview | ScienceDirect Topics
Mendelian Randomization Study of ACLY and Cardiovascular Disease | NEJM
Validation of ACLY as a specific target of DCV with a recombinant... | Download Scientific Diagram
Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor - eBioMedicine
Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders: Trends in Molecular Medicine
Targeting cancer metabolism in the era of precision oncology | Nature Reviews Drug Discovery
ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation | eLife
ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation | eLife
Mendelian Randomization Study of ACLY and Cardiovascular Disease | NEJM
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism - ScienceDirect
The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis: Trends in Molecular Medicine
ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation | eLife
Tyrosine phosphorylation is critical for ACLY activity in lipid metabolism and cancer | bioRxiv
Inhibitors of lipogenic enzymes as a potential therapy against cancer - Montesdeoca - 2020 - The FASEB Journal - Wiley Online Library
ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation | eLife
PDF) Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening study
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism - ScienceDirect
Cancers | Free Full-Text | ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker | HTML
Frontiers | Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma | Oncology
Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques | Nature Communications
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr−/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Exploring the Role of ATP-Citrate Lyase in the Immune System | Immunology
An allosteric mechanism for potent inhibition of human ATP-citrate lyase | Nature
Cell-based validation of ACLY as a functional target of DCV. (A)... | Download Scientific Diagram
